B2B Central

China

23 Mar 2021

IFF launches new range of anti-staling amylases in China

By Staff Writer

IFF has launched POWERFresh and POWERSoft range of enzymes in China. These products are marketed under the Danisco range of food ingredients that is now part of the IFF family. Freshness solution Improver houses and bakeries in China are always looking to enhance consumer eating experiences, while improving productivity and reducing product returns. To help...
23 Mar 2021

BlackRock: Our views on Chinese assets

By Staff Writer

BlackRock Investment Institute Chinese stocks have sold off on concerns that China could tighten monetary and fiscal policy more aggressively – after having led the global restart and policy normalization. This took place as rising U.S. Treasury yields have pressured global risk assets. We see moderately reduced tightening risk after China’s parliament meeting, and keep...
16 Feb 2021

China’s economic power requires rethink of traditional global investment management

By Staff Writer

China has long been classified as an “emerging” economy characterized by high GDP growth rates and a growing middle class but lacking the robust institutions, governance and economic dynamism of the more established “developed” nations.
10 Feb 2021

Investing in China in the Year of the Ox

By Staff Writer

Stepping into the Year of the Ox, HSBC Global Asset Management believes that the macro recovery in China will continue to lead the global market in a post-COVID context.
22 Oct 2020

Relationship problems

By Staff Writer

By: Robert White, senior analyst, Momentum Global Investment Management With the US election now just around the corner, investors are busy forming expectations on the result and looking at the potential policy implications of either a Biden or Trump victory. While there is plenty of short-term focus on the eventual shape of any additional stimulus...
23 Jun 2020

Arla Foods launches whey ingredient that slows age-related muscle decline

By Staff Writer

Arla Foods Ingredients has launched a new whey protein ingredient which is clinically proven to counteract age-related muscle mass decline. Lacprodan HYDRO.Rebuild is a 100% hydrolysed whey protein. It offers highly accessible content of branched-chain amino acids and essential amino acids such as leucine, which are important for muscle synthesis in seniors. Significant improvements to...
10 Apr 2020

COVID-19: Prescient's view from China

By Janice Roberts

At Prescient, we don’t usually comment on anything other than quantitative factors, the interpretation of data and what our models are telling us. We believe that investments should be based on research and facts, and that emotions are counterproductive to successful investment decisions.
02 Apr 2020

Naspers contributes over a billion rand to stop the spread of COVID-19 in SA

By Staff Writer

Naspers has committed R1.5bn in emergency aid to the South African government’s response to the Covid-19 crisis. The group will contribute R500m to the Solidarity Response Fund announced by President Cyril Ramaphosa last week. In addition, Naspers will buy R1bn worth of personal protective equipment and other medical supplies in China – in partnership with...
05 Mar 2020

February market review: Fears about the coronavirus

By Janice Roberts

February kicked off with ill-boding, as international investors erased $393 billion from China's benchmark stock index and dumped commodities on fears about the coronavirus and its economic impact.
06 Feb 2020

Coronavirus: Markets rally – growing bubble or knee-jerk reaction?

By Janice Roberts

Global financial markets are shrugging off uncertainty regarding the serious and ongoing international issue of the coronavirus outbreak – but beware of a bubble, warns CEO of deVere Group, Nigel Green. This comes as U.S. stocks closed on Wednesday at record highs, and as the FTSE 100 and European stocks staged a comeback after taking...
04 Feb 2020

How we should think about potentially disastrous events in an investment context

By Janice Roberts

The continued rapid spread of the Wuhan coronavirus – which goes by the technical name of 2019-nCov – is still dominating the headlines and markets have predictably been under pressure over the past few weeks.

03 Feb 2020

Prepare for the risks of Novel Coronavirus

By Janice Roberts

On 30 January 2020, the Director-General of the World Health Organisation (WHO) declared that the outbreak of the novel coronavirus (“2019-nCoV”) constitutes a Public Health Emergency of International Concern (PHEIC) and issued advice as Temporary Recommendations (TR) under the International Health Regulations (IHR).